Found 471 investors
Synergis Capital
Canada
Founded in 2018, Synergis Capital is a venture capital firm based in Toronto, Canada. The firm seeks to invest in SaaS, biotechnology and consumer service sectors.
Venture Capital
Synet Ventures
United States
Founded in 2000, Synet Ventures is a venture capital firm headquartered in Minneapolis, Minnesota. The firm prefers to invest in the SaaS, biotechnology, and information technology sectors.
Venture Capital
Syzygy Therapeutics Management
United States
Founded in 2010, Syzygy Therapeutics Management was a venture capital firm based in New York, New York. The firm invested in the biotechnology and pharmaceutical sectors.
Venture Capital
S√Єren Carlsen
Copenhagen, Hovedstaden, Denmark
Soren Carlsen has been employed with the Novo Group since 1979. He was appointed Vice President of Biotechnology in 1986, and in 1991-92 he ...
Investment Partner
Taproot Ventures
Portland, Oregon, United States
Taproot Ventures LLC, a California-based venture firm, that there was a large focus on nanomaterial use in biotechnology
Biotechnology
Finance
Venture Capital
Venture Capital
Taraval Associates
United States
Taraval Associates is a venture capital firm that is based in Menlo Park, California. The firm focuses on companies in the healthcare, agriculture, biotechnology and chemical process sectors.
Venture Capital
Tatsuya Masubuchi
United States
Mr. David Griffith serves as Chairman at Modern Group. He has worked for more than 20 years at Modern Group as Chairman, President, and Chief Executive Officer. In May of 2013, he stepped down from day-to-day operations and assumed the role of Chairman. He is also the Executive Director of Episcopal Community Services, Chairman of Delaware Valley Floral Group, and a director of the JJ Haines Company and Mountain Laurel Spirits. He is also Vice Chairman of the Philadelphia World Affairs Council and a Director of the Hepatitis B Foundation and the PA Biotechnology Center and a member of the IBM MidMarket advisory council. He is also Chairman of the McEwen Family Scholarship Trust which benefits children of Modern employees. He is a past president of MHEDA and president of the Hyster Dealer Council. He also serves as Chairman of the Board at the Academy of Natural Sciences of Drexel University Endowment. He is also a past director of NAW and a past trustee of the Westminster School. Prior to Modern, he was an executive with IBM, ROLM, and MCI. He graduated from Kenyon College and Westminster.
Individual/Angel
TCL Venture Capital
China
Founded in 2009, TCL Venture Capital is a venture capital firm headquartered in Shenzhen, China. The firm makes growth capital investments in the medical treatment, energy, environment protection, IPTV, new materials, biotechnology, culture, power electronics and traditional media sectors.
Venture Capital
TeamVest Capital
Poland
Founded in 2016, TeamVest Capital is a venture capital investment firm based in Warsaw, Poland. The firm focuses in the innovative European technology companies in growth and establishment phase as well as in expansion phase. It seeks to invest in the information technology, SaaS applications, big data, internet, biotechnology and new materials sectors.
Venture Capital
TechAcq Ventures
United States
Founded in 1996, TechAcq Ventures is a venture capital firm headquartered in La Jolla, California with a presence in San Francisco, New York, and the Pacific Northwest. The firm seeks to invest in companies operating in the biotechnology, clean-tech, food, agriculture, healthcare, life sciences, diagnostics, pharmaceuticals, nanotechnology, software, and data sectors.
Venture Capital
Technology Funding
United States
Technology Funding was a venture capital firm based in Santa Fe, New Mexico. The firm invested in early-stage or startup medical and biotechnology companies. The firm was founded in 1979.
Venture Capital
Tellus BioVentures
United States
Tellus BioVentures is a biotechnology investment fund focused on early-stage innovation and company formation. We make select early investments at the Seed stage in private biotech ventures as the lead or sole investor and participate in Series-A investments.
Venture Capital
Temasek Life Sciences Ventures
Singapore
Temasek Life Sciences Ventures was a Venture capital firm based in Singapore, Singapore. The firm preferred to invest in companies operating in the biotechnology, renewables, industrial microbiology, health care and the life sciences sectors.
Venture Capital
The Aentib Group
United States
Founded in 1995, The Aentib Group is a vebture capital firm based in New York, New York. The firm prefers to invest in the healthcare, biotechnology and technology sectors.
Venture Capital
The Column Group
San Francisco, California, United States
The Column Group is a California-based venture capital firm dedicated to developing biotechnology companies.
Finance
Financial Services
Venture Capital
Venture Capital
The Elephant (Israeli)
Israel
The Elephant (Israeli) is an investment firm based in Tel Aviv, Israel. The firm prefers to invest in the SaaS, analytics, big data, automotive, autonomous tech, banking, biotechnology, business intelligence, food, gaming, healthcare, logistics, cybersecurity, education, e-commerce, transportation, biotechnology, data management, drones, financial technology, blockchain, enterprice software and information technology sectors.
Other
The Reich Group
Miami Beach, Florida, United States
Early Stage Investments in Biotechnology
Venture Capital
The Vertical Group
Basking Ridge, New Jersey, United States
The Vertical Group is a New Jersey-based venture capital firm focused on the fields of medical technology and biotechnology.
Biotechnology
Health Care
Venture Capital
Micro VC
Thia Ventures
Switzerland
Thia Ventures is a venture capital firm headquartered in Geneva, Switzerland. The firm seeks to invest in the nutrition, health, and biotechnology sectors. The firm is a joint initiative of Ambrosia Investment and Xia.
Venture Capital
Thomas Albert
United States
Mr. Frank Leo serves as a Board of Director at Ocugen. Frank is a 30-year veteran of the pharmaceutical and healthcare industries having experience with publicly-traded, private equity-backed, and start-up companies in the capacity of executive, investor, and advisor. From 1999 to 2004, Mr. Leo served as President and Group President of Sterile Technologies and Life Sciences at Cardinal Health. He joined Cardinal Health following its acquisition of the sterile pharmaceutical contract manufacturing company Automatic Liquid Packing (ALP), where he held various senior level positions including Chief Operating Officer during his 16-year career. At Cardinal Health he oversaw the growth of the biotechnology and life sciences group, which was later spun out to form Catalent Inc. Mr. Leo left Cardinal Health in 2004 but continued to serve as a retained advisor through 2005. Mr. Leo joined Morton Grove Pharmaceuticals where he served as CEO from 2006 to 2007, overseeing its sale for its private equity owners in 2007. Mr. Leo served as a Board Member of Rx Elite, Monogen, GeneraMedix, and Capsugel. Mr. Leo is a serial entrepreneur, having been involved in business value creation and start-ups in the sterile drug, biotechnology and healthcare technology spaces.
Individual/Angel
Showing 401 to
420 of
471 results